BRPI0510930A - vacinas de subunidade de prrsv - Google Patents

vacinas de subunidade de prrsv

Info

Publication number
BRPI0510930A
BRPI0510930A BRPI0510930-2A BRPI0510930A BRPI0510930A BR PI0510930 A BRPI0510930 A BR PI0510930A BR PI0510930 A BRPI0510930 A BR PI0510930A BR PI0510930 A BRPI0510930 A BR PI0510930A
Authority
BR
Brazil
Prior art keywords
prrsv
vaccines
combination
subunit vaccines
orf1
Prior art date
Application number
BRPI0510930-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Eric M Vaughn
Richard Stammer
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of BRPI0510930A publication Critical patent/BRPI0510930A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10071—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0510930-2A 2004-06-17 2005-06-17 vacinas de subunidade de prrsv BRPI0510930A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58135004P 2004-06-17 2004-06-17
US11/154,617 US7722878B2 (en) 2004-06-17 2005-06-16 PRRSV subunit vaccines
PCT/US2005/021973 WO2006002193A2 (en) 2004-06-17 2005-06-17 Prrsv subunit vaccines

Publications (1)

Publication Number Publication Date
BRPI0510930A true BRPI0510930A (pt) 2007-11-20

Family

ID=35431312

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510930-2A BRPI0510930A (pt) 2004-06-17 2005-06-17 vacinas de subunidade de prrsv

Country Status (14)

Country Link
US (1) US7722878B2 (OSRAM)
EP (1) EP1755664B1 (OSRAM)
JP (1) JP2008503221A (OSRAM)
KR (1) KR20070028431A (OSRAM)
AR (1) AR049825A1 (OSRAM)
AU (1) AU2005258092A1 (OSRAM)
BR (1) BRPI0510930A (OSRAM)
CA (1) CA2570778A1 (OSRAM)
DK (1) DK1755664T3 (OSRAM)
ES (1) ES2546933T3 (OSRAM)
MX (1) MXPA06014821A (OSRAM)
RU (1) RU2007101531A (OSRAM)
TW (1) TW200603825A (OSRAM)
WO (1) WO2006002193A2 (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839912A1 (en) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
PL204373B1 (pl) 1999-03-08 2010-01-29 Boehringer Ingelheim Vetemendi Replikony zespołu reprodukcyjnego i oddechowego świń (PRRSV), zastosowanie replikonów PRRSV, szczepionki zawierające replikony PRRSV i zastosowanie tych szczepionek
AU4482200A (en) 1999-04-22 2000-11-10 United States Department Of Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
SG153829A1 (en) 2004-06-18 2009-07-29 Univ Minnesota Identifying virally infected and vaccinated organisms
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
PL2369001T3 (pl) 2005-06-24 2017-06-30 Regents Of The University Of Minnesota Wirusy PRRS, ich klony zakaźne, mutanty i sposoby stosowania
US8436337B2 (en) * 2009-05-12 2013-05-07 The State of Oregon Acting By and Through The State Board of Higher Education on Behalf of Oregon State Unitiversity Amorphous multi-component metallic thin films for electronic devices
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
EP2675476B1 (en) 2011-02-17 2015-09-16 Boehringer Ingelheim Vetmedica GmbH Commercial scale process for production of prrsv
PL2675475T3 (pl) 2011-02-17 2015-12-31 Boehringer Ingelheim Vetmedica Gmbh Nowy europejski szczep prrs
WO2012129176A1 (en) * 2011-03-18 2012-09-27 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Amorphous multi-component metal/metal oxide nanolaminate metamaterials and devices based thereon
EP2712927B1 (en) 2011-05-07 2019-08-21 Laboratorio Avi-Mex, S.A. De C.V. Recombinant vaccine against prrs in a viral vector
WO2013017568A1 (en) 2011-07-29 2013-02-07 Boehringer Ingelheim Vetmedica Gmbh INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
US9187731B2 (en) * 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
US9099230B2 (en) 2012-11-12 2015-08-04 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State Univesity Amorphous metal thin-film non-linear resistor
US9579373B2 (en) 2013-03-15 2017-02-28 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
JP6886291B2 (ja) 2013-12-20 2021-06-16 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハーＢｏｅｈｒｉｎｇｅｒ Ｉｎｇｅｌｈｅｉｍ Ｖｅｔｍｅｄｉｃａ ＧｍｂＨ ＰＲＲＳウイルス変異株、ヨーロッパ型ＰＲＲＳウイルスｃＤＮＡクローンおよびそれらの使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592873B1 (en) * 1992-10-30 2003-07-15 Iowa State University Research Foundation, Inc. Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
US6773908B1 (en) * 1992-10-30 2004-08-10 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US20020012670A1 (en) * 2000-01-26 2002-01-31 Knut Elbers Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV)
US6841364B2 (en) * 2002-01-22 2005-01-11 Protatek International, Inc. Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof

Also Published As

Publication number Publication date
US7722878B2 (en) 2010-05-25
EP1755664A2 (en) 2007-02-28
WO2006002193A2 (en) 2006-01-05
MXPA06014821A (es) 2007-03-26
CA2570778A1 (en) 2006-01-05
RU2007101531A (ru) 2008-07-27
DK1755664T3 (en) 2015-08-24
WO2006002193A3 (en) 2006-03-02
US20080038293A1 (en) 2008-02-14
TW200603825A (en) 2006-02-01
JP2008503221A (ja) 2008-02-07
AR049825A1 (es) 2006-09-06
AU2005258092A1 (en) 2006-01-05
EP1755664B1 (en) 2015-06-10
KR20070028431A (ko) 2007-03-12
ES2546933T3 (es) 2015-09-30

Similar Documents

Publication Publication Date Title
BRPI0510930A (pt) vacinas de subunidade de prrsv
SG170090A1 (en) Immunogenic composition
MX2010012999A (es) Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso.
TNSN07387A1 (en) C.perfringens alpha toxoid vaccine
WO2006032500A3 (en) Immunogenic composition
IL201429A (en) Weakened live virus compositions and methods to reduce disabling live viruses
IN2014DN08830A (OSRAM)
MX2011006256A (es) Composiciones y procedimientos para controlar enfermedades en animales.
PH12021550479A1 (en) Dengue vaccine unit dose and administration thereof
AU2009326524A8 (en) Use of Flt3 ligand for strengthening immune responses in RNA immunization
MX2009003378A (es) Concentrados en suspension para la mejora de la absorcion por la raiz de principios activos agroquimicos.
PH12013502436A1 (en) Combined vaccines for prevention of porcine virus infections
PH12021551071A1 (en) A nutritional composition comprising 6`sl and lnt in combination to improve the gastrointestinal barrier function
MXPA02004627A (es) Vacunas contra el micoplasma bovis y sus metodos de uso.
WO2007002470A3 (en) Inactivated chimeric vaccines and related methods of use
TW200515917A (en) Methods and compositions for the generation of a protective immune response against SARS-COV
UA97359C2 (en) Immunogenic composition
WO2011084967A3 (en) Methods and compositions for providing protective immunity in the elderly
WO2008014570A3 (en) Treatment and prevention of allergic airways diseases
MY158116A (en) Combination vaccine against streptococcus
PH12022550261A1 (en) Methods for preventing dengue and hepatitis a
TW200806314A (en) Immunogenic composition
EA200600466A1 (ru) Фармацевтическая композиция, пригодная для использования, в частности, в качестве антивирусного, антибактериального средства и для стимулирования иммунной защиты
ATE495757T1 (de) Attenuierte bakterielle lebendvakzine
UA102145C2 (ru) Иммуногенная композиция, которая содержит lawsonia intracellularis

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]